Fundraising Fox
Enedra Therapeutics
3 known investors
Find your way into Enedra Therapeutics
Sign up to see every warm intro you have to Enedra Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Enedra Therapeutics team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Enedra analyzes tumor evolution patterns by decoding convergent genomic signatures from cancer genomic data. The company uses its CASPAROV platform to identify conserved genetic patterns across tumor populations and cancer models.
Investors · 3
Deep Science Ventureslisted by Deep Science VenturesLondon
How we know: Deep Science Ventures's portfolio page · Not right? Tell us
KU Leuven Research & Developmentlisted by KU Leuven Research & Development
How we know: KU Leuven Research & Development's portfolio page · Not right? Tell us
O2h Ventureslisted by O2h VenturesCambridge
How we know: O2h Ventures's portfolio page · funding news · press coverage · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountseed roundDec 2025Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Enedra Therapeutics do?
- Enedra analyzes tumor evolution patterns by decoding convergent genomic signatures from cancer genomic data. The company uses its CASPAROV platform to identify conserved genetic patterns across tumor populations and cancer models.
- Who are Enedra Therapeutics's investors?
- Enedra Therapeutics's investors include Deep Science Ventures, KU Leuven Research & Development, O2h Ventures.